Article Versions Notes

Swami U, Chennamadhavuni A, Borcherding N, Bossler AD, Mott SL, Garje R, Zakharia Y, Milhem M. Multivariable Analysis of 169 Cases of Advanced Cutaneous Melanoma to Evaluate Antibiotic Exposure as Predictor of Survival to Anti-PD-1 Based Immunotherapies. Antibiotics. 2020; 9(11):740. https://doi.org/10.3390/antibiotics9110740

Swami, Umang, Adithya Chennamadhavuni, Nicholas Borcherding, Aaron D. Bossler, Sarah L. Mott, Rohan Garje, Yousef Zakharia, and Mohammed Milhem. 2020. "Multivariable Analysis of 169 Cases of Advanced Cutaneous Melanoma to Evaluate Antibiotic Exposure as Predictor of Survival to Anti-PD-1 Based Immunotherapies" Antibiotics 9, no. 11: 740. https://doi.org/10.3390/antibiotics9110740

Swami, U., Chennamadhavuni, A., Borcherding, N., Bossler, A. D., Mott, S. L., Garje, R., Zakharia, Y., & Milhem, M. (2020). Multivariable Analysis of 169 Cases of Advanced Cutaneous Melanoma to Evaluate Antibiotic Exposure as Predictor of Survival to Anti-PD-1 Based Immunotherapies. Antibiotics, 9(11), 740. https://doi.org/10.3390/antibiotics9110740